Ningbo Sanxing Medical Electric Co.,Ltd. (601567.SS)
CNY 28.51
(-4.17%)
CNY 28.51
(-4.17%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 11.37 Billion CNY | 25.07% |
| 2022 | 9.09 Billion CNY | 29.55% |
| 2021 | 7.02 Billion CNY | -0.98% |
| 2020 | 7.09 Billion CNY | 5.25% |
| 2019 | 6.73 Billion CNY | 14.8% |
| 2018 | 5.87 Billion CNY | 9.35% |
| 2017 | 5.36 Billion CNY | 9.08% |
| 2016 | 4.92 Billion CNY | 18.37% |
| 2015 | 4.15 Billion CNY | 44.69% |
| 2014 | 2.87 Billion CNY | 27.91% |
| 2013 | 2.24 Billion CNY | -12.3% |
| 2012 | 2.56 Billion CNY | 3.34% |
| 2011 | 2.47 Billion CNY | 37.59% |
| 2010 | 1.8 Billion CNY | 21.16% |
| 2009 | 1.48 Billion CNY | 30.3% |
| 2008 | 1.14 Billion CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 3.94 Billion CNY | 31.24% |
| 2024 Q3 | 3.43 Billion CNY | -12.95% |
| 2024 Q1 | 3 Billion CNY | -3.01% |
| 2023 Q4 | 3.1 Billion CNY | 11.19% |
| 2023 FY | 11.37 Billion CNY | 25.07% |
| 2023 Q1 | 2.24 Billion CNY | 2.35% |
| 2023 Q2 | 3.3 Billion CNY | 46.79% |
| 2023 Q3 | 2.78 Billion CNY | -15.5% |
| 2022 Q2 | 2.41 Billion CNY | 21.85% |
| 2022 Q1 | 1.98 Billion CNY | 3.29% |
| 2022 FY | 9.09 Billion CNY | 29.55% |
| 2022 Q4 | 2.19 Billion CNY | -12.25% |
| 2022 Q3 | 2.5 Billion CNY | 3.64% |
| 2021 Q1 | 1.38 Billion CNY | -13.33% |
| 2021 Q2 | 1.95 Billion CNY | 40.91% |
| 2021 FY | 7.02 Billion CNY | -0.98% |
| 2021 Q4 | 1.91 Billion CNY | 9.15% |
| 2021 Q3 | 1.75 Billion CNY | -10.13% |
| 2020 Q2 | 2.12 Billion CNY | 55.9% |
| 2020 Q1 | 1.36 Billion CNY | -27.28% |
| 2020 FY | 7.09 Billion CNY | 5.25% |
| 2020 Q3 | 2 Billion CNY | -5.86% |
| 2020 Q4 | 1.6 Billion CNY | -19.94% |
| 2019 FY | 6.73 Billion CNY | 14.8% |
| 2019 Q2 | 1.72 Billion CNY | 28.13% |
| 2019 Q3 | 1.79 Billion CNY | 4.03% |
| 2019 Q4 | 1.87 Billion CNY | 4.52% |
| 2019 Q1 | 1.34 Billion CNY | -18.96% |
| 2018 Q2 | 1.43 Billion CNY | 24.42% |
| 2018 Q1 | 1.15 Billion CNY | -39.32% |
| 2018 FY | 5.87 Billion CNY | 9.35% |
| 2018 Q4 | 1.66 Billion CNY | 2.29% |
| 2018 Q3 | 1.62 Billion CNY | 13.24% |
| 2017 FY | 5.36 Billion CNY | 9.08% |
| 2017 Q4 | 1.89 Billion CNY | 29.64% |
| 2017 Q3 | 1.46 Billion CNY | 35.87% |
| 2017 Q2 | 1.07 Billion CNY | 16.45% |
| 2017 Q1 | 925.91 Million CNY | -47.56% |
| 2016 Q3 | 1.24 Billion CNY | 11.72% |
| 2016 Q2 | 1.11 Billion CNY | 40.62% |
| 2016 Q1 | 793.53 Million CNY | -46.12% |
| 2016 FY | 4.92 Billion CNY | 18.37% |
| 2016 Q4 | 1.76 Billion CNY | 41.63% |
| 2015 Q1 | 548.06 Million CNY | -44.86% |
| 2015 Q2 | 1.06 Billion CNY | 94.67% |
| 2015 Q4 | 1.47 Billion CNY | 37.58% |
| 2015 Q3 | 1.07 Billion CNY | 0.33% |
| 2015 FY | 4.15 Billion CNY | 44.69% |
| 2014 Q4 | 993.86 Million CNY | 12.49% |
| 2014 Q3 | 883.48 Million CNY | 52.88% |
| 2014 Q2 | 577.91 Million CNY | 38.07% |
| 2014 Q1 | 418.56 Million CNY | -40.73% |
| 2014 FY | 2.87 Billion CNY | 27.91% |
| 2013 Q1 | 466.72 Million CNY | -45.05% |
| 2013 FY | 2.24 Billion CNY | -12.3% |
| 2013 Q4 | 706.21 Million CNY | 23.32% |
| 2013 Q3 | 572.68 Million CNY | 14.3% |
| 2013 Q2 | 501.05 Million CNY | 7.35% |
| 2012 FY | 2.56 Billion CNY | 3.34% |
| 2012 Q3 | 670.59 Million CNY | 22.01% |
| 2012 Q4 | 849.36 Million CNY | 26.66% |
| 2012 Q2 | 549.6 Million CNY | 11.67% |
| 2012 Q1 | 492.18 Million CNY | -47.03% |
| 2011 Q3 | 630.33 Million CNY | 39.72% |
| 2011 Q1 | 468.23 Million CNY | -29.22% |
| 2011 Q2 | 451.15 Million CNY | -3.65% |
| 2011 Q4 | 929.2 Million CNY | 47.41% |
| 2011 FY | 2.47 Billion CNY | 37.59% |
| 2010 FY | 1.8 Billion CNY | 21.16% |
| 2010 Q4 | 661.5 Million CNY | 43.47% |
| 2010 Q3 | 461.07 Million CNY | 0.0% |
| 2009 FY | 1.48 Billion CNY | 30.3% |
| 2008 FY | 1.14 Billion CNY | 0.0% |